References
Kusari A, Sprague J, Eichenfield LF, Matiz C, Barrio VR. Primary cutaneous aspergillosis at the site of cyanoacrylate skin adhesive in a neonate. Pediatr Dermatol. 2018 May 15. doi: 10.1111/pde.13528 Article
Kimura H, Mitsuto I, Taguchi R, Anzawa K, Mochizuki T. Primary cutaneous aspergillosis caused by Aspergillus tamarii in a premature infant with extremely low birthweight: A case report with short review. J Dermatol. 2018 May;45(5):622-625. doi: 10.1111/1346-8138.14263. Article
Amod FC, Coovadia YM, Pillay T, Ducasse G. Primary cutaneous aspergillosis in ventilated neonates. Pediatr Infect Dis J. 2000 May;19(5):482-3 Article
Leibovitz E, Juster-Reicher A, Flidel-Rimon O, Amaitay M, Shinwell E. High-dose liposomal amphotericin B (AmBisome) in the therapy of neonatal systemic candidiasis in very low birth weight infants. In Abstracts of the 11th Meeting of the International Immunocompromised Host Society, abstract 71. International Immunocompromised Host Society, Dacula, GA (2000).
Linder N, Shalit I, Tallen-Gozani E, Ashkenazi S, Levi I, Haski G, Rosen E, Sirota L. Amphotericin B colloidal dispersion use in very low birth weight infants. In Abstracts of the 2000 Pediatric Academic Societies and American Academy of Pediatrics Joint Meeting, abstract 2438. American Academy of Pediatrics, Boston (2000).
Mahieu LM, De Dooy JJ, Van Laer FA, Jansens H, Ieven MM. A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect. 2000 Jul;45(3):191-7 Article
van Landeghem FK, Stiller B, Lehmann TN, Sarioglu N, Sander B, Lange PE, Stoltenburg-Didinger G. Aqueductal stenosis and hydrocephalus in an infant due to aspergillus infection. Clin Neuropathol. 2000 Jan-Feb;19(1):26-9 PubMed
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000 May;79(3):155-69Article
Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999 Oct;41(5):589-93 Article
Reddy SC, Sharma HS, Mazidah AS, Darnal HK, Mahayidin M. Orbital abscess due to acute ethmoiditis in a neonate. Int J Pediatr Otorhinolaryngol. 1999 Jun 15;49(1):81-6 Article
Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999 Mar 11;340(10):764-71 Article
Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J. 1999 Aug;18(8):702-8 Article
Meessen NE, Oberndorff KM, Jacobs JA. Disseminated aspergillosis in a premature neonate. J Hosp Infect. 1998 Nov;40(3):249-50 Article
Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J. 1998 Feb;17(2):146-8 Article
Singer S, Singer D, Rüchel R, Mergeryan H, Schmidt U, Harms K. Outbreak of systemic aspergillosis in a neonatal intensive care unit. Mycoses. 1998 May-Jun;41(5-6):223-7 Article
Weitkamp JH, Poets CF, Sievers R, Musswessels E, Groneck P, Thomas P, Bartmann P. Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection. 1998 Jan-Feb;26(1):11-5 Article
Walsh TJ. Primary cutaneous aspergillosis–an emerging infection among immunocompromised patients. Clin Infect Dis. 1998 Sep;27(3):453-7 Article
Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol. 1997 Sep;98(3):711-8 Article
Groll AH, Jaeger G, Allendorf A, Herrmann G, Schloesser R, von Loewenich V. Invasive pulmonary aspergillosis in a critically ill neonate: case report and review of invasive aspergillosis during the first 3 months of life. Clin Infect Dis. 1998 Sep;27(3):437-52 Article
Kingo AR, Smyth JA, Waisman D. Lack of evidence of amphotericin B toxicity in very low birth weight infants treated for systemic candidiasis. Pediatr Infect Dis J. 1997 Oct;16(10):1002-3Article
Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis. 1996;16:277-99 Article
Gupta M, Weinberger B, Whitley-Williams PN. Cutaneous aspergillosis in a neonate. Pediatr Infect Dis J. 1996 May;15(5):464-5 Article
Papouli M, Roilides E, Bibashi E, Andreou A. Primary cutaneous aspergillosis in neonates: case report and review. Clin Infect Dis. 1996 Jun;22(6):1102-4 Article
Walsh TJ, Gonzalez C, Lyman CA, Chanock SJ, Pizzo PA. Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis. 1996;11:187-290 PubMed
Botas CM, Kurlat I, Young SM, Sola A. Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics. 1995 Jun;95(6):883-7 Article
Kavelaars A, Zijlstra J, Bakker JM, Van Rees EP, Visser GH, Zegers BJ, Heijnen CJ. Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur J Immunol. 1995 May;25(5):1346-51 Article
Lewis DB, Wilson CB. Developmental immunology and role of host defenses in neonatal susceptibility to infection. In: Remington JS, Klein JO, eds. Infectious Diseases of the fetus and newborn infant. 4th ed. Philadelphia, PA: WB Saunders, 1995; 50-68.
Mouy R, Ropert JC, Donadieu J, Hubert P, de Blic J, Revillon Y, Brunelle F, Schollet Martin S, Descamps B, Debré M, et al. [Chronic septic granulomatosis revealed by neonatal pulmonary aspergillosis]. Arch Pediatr. 1995 Sep;2(9):861-4 Article
Rowen JL, Atkins JT, Levy ML, Baer SC, Baker CJ. Invasive fungal dermatitis in the < or = 1000-gram neonate.Pediatrics. 1995 May;95(5):682-7 Article
Schloesser RL, Rettwitz-Volk W, Groll A, v.Loewenich V. Generalisierte Pilzinfektionen bei neonatologischen Patienten. Monatsschr Kinderheilkd 1995; 143: 406.
Sugar AM. Use of amphotericin B with azole antifungal drugs: what are we doing?. Antimicrob Agents Chemother. 1995 Sep;39(9):1907-12 Article
van den Anker JN, van Popele NM, Sauer PJ. Antifungal agents in neonatal systemic candidiasis. Antimicrob Agents Chemother. 1995 Jul;39(7):1391-7 Article
Francis P, Lee JW, Hoffman A, Peter J, Francesconi A, Bacher J, Shelhamer J, Pizzo PA, Walsh TJ. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J Infect Dis. 1994 Feb;169(2):356-68 PubMed
Gonzalez LA, Kiff JE, Umetsu DT. A three-week-old infant with invasive pulmonary aspergillosis. Ann Allergy. 1994 Nov;73(5):392-400 PubMed
Charles B, Schild P, Steer P, Cartwright D, Donovan T. Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther. 1993;20(3-4):205-10 PubMed
Glick C, Graves GR, Feldman S. Neonatal fungemia and amphotericin B. South Med J. 1993 Dec;86(12):1368-71 Article
Perzigian RW, Faix RG. Primary cutaneous aspergillosis in a preterm infant. Am J Perinatol. 1993 Jul;10(4):269-71 PubMed
Quie PG. Chronic granulomatous disease of childhood: a saga of discovery and understanding. Pediatr Infect Dis J. 1993 May;12(5):395-8 Article
van den Anker JN, Wildervanck de Blecourt-Devilee M, Sauer PJ. Severe endophthalmitis after neonatal skin lesions with positive cultures of Aspergillus fumigatus. Eur J Pediatr. 1993 Aug;152(8):699-700 Article
Walmsley S, Devi S, King S, Schneider R, Richardson S, Ford-Jones L. Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J. 1993 Aug;12(8):673-82 Article
Bhandari V, Narang A. Oral itraconazole therapy for disseminated candidiasis in low birth weight infants. J Pediatr. 1992 Feb;120(2 Pt 1):330 Article
Francis P, Walsh TJ. Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy. Clin Infect Dis. 1992 Dec;15(6):1003-18Article
Jusko WJ, Ludwig EA. Corticosteroids. In: Evans WI, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics. 3rd edition Vancouver WN: Applied Therapeutics, 1992: 27.1-27.34.
Lackner H, Schwinger W, Urban C, Müller W, Ritschel E, Reiterer F, Kuttnig-Haim M, Urlesberger B, Hauer C. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics. 1992 Jun;89(6 Pt 2):1259-61 Article
Leibovitz E, Iuster-Reicher A, Amitai M, Mogilner B. Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience. Clin Infect Dis. 1992 Feb;14(2):485-91 Article
Rowen JL, Correa AG, Sokol DM, Hawkins HK, Levy ML, Edwards MS. Invasive aspergillosis in neonates: report of five cases and literature review. Pediatr Infect Dis J. 1992 Jul;11(7):576-82 Article
van den Anker JN. Treatment of neonatal Candida albicans septicemia with itraconazole. Pediatr Infect Dis J. 1992 Aug;11(8):684-5 PubMed
Van den Anker JN, Koster M, Woestenborghs R, Sauer PJJ. Itraconazole serum levels in the preterm neonate. Chemotherapy 1992; 38: 58.
Green M, Wald ER, Tzakis A, Todo S, Starzl TE. Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis. 1991 Jul-Aug;13(4):653-7 Article
Roth JG, Troy JL, Esterly NB. Multiple cutaneous ulcers in a premature neonate. Pediatr Dermatol. 1991 Sep;8(3):253-5 Article
Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990 May;116(5):791-7 Article
Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 1990 Jan;9(1):51-6 Article
. .
Lortie C, King GM, Adamson IY. Effects of dexamethasone on macrophages in fetal and neonatal rat lung. Pediatr Pulmonol. 1990;8(3):138-44 Article
Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413-37Article
Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989 Apr;114(4 Pt 1):555-60 Article
Pereira S, Radotra B, Pereira BJ, Singhi SC. Disseminated neonatal aspergillosis. Indian Pediatr. 1989 Jun;26(6):584-7 PubMed
Butler KM, Baker CJ. Candida: an increasingly important pathogen in the nursery. Pediatr Clin North Am. 1988 Jun;35(3):543-63 PubMed
Googe JH, Walterspiel JN. Arrhythmia caused by amphotericin B in a neonate. Pediatr Infect Dis J. 1988 Jan;7(1):73 Article
Goren MP, Viar MJ, Shenep JL, Wright RK, Baker DK, Kalwinsky DK. Monitoring serum aminoglycoside concentrations in children with amphotericin B nephrotoxicity. Pediatr Infect Dis J. 1988 Oct;7(10):698-703 Article
Koren G, Lau A, Klein J, Golas C, Bologa-Campeanu M, Soldin S, MacLeod SM, Prober C. Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr. 1988 Sep;113(3):559-63 Article
Schwartz DA, Jacquette M, Chawla HS. Disseminated neonatal aspergillosis: report of a fatal case and analysis of risk factors. Pediatr Infect Dis J. 1988 May;7(5):349-53 Article
Raghavan R, Date A, Bhaktaviziam A. Systemic fungal infections in south Indian infants. Ann Trop Paediatr. 1987 Jun;7(2):139-41 PubMed
Schoumacher RA, Tiller RE, Berkow RL. Invasive pulmonary aspergillosis in an infant: an unusual presentation of chronic granulomatous disease. Pediatr Infect Dis J. 1987 Feb;6(2):215-7 Article
Sihota R, Agarwal HC, Grover AK, Sood NN. Aspergillus endophthalmitis. Br J Ophthalmol. 1987 Aug;71(8):611-3 Article
Starke JR, Mason EO Jr, Kramer WG, Kaplan SL. Pharmacokinetics of amphotericin B in infants and children. J Infect Dis. 1987 Apr;155(4):766-74 Article
Rhine WD, Arvin AM, Stevenson DK. Neonatal aspergillosis. A case report and review of the literature. Clin Pediatr (Phila). 1986 Aug;25(8):400-3 Article
Krasinski K, Holzman RS, Hanna B, Greco MA, Graff M, Bhogal M. Nosocomial fungal infection during hospital renovation. Infect Control. 1985 Jul;6(7):278-82 Article
Mouy R, Bremard C, Fischer A, Huu Trong P, Vilmer E, Griscelli C. [Aspergillus infection and chronic septic granulomatosis]. Arch Fr Pediatr. 1985 Dec;42 Suppl 2:953-7 PubMed
Faix RG. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J Pediatr. 1984 Oct;105(4):616-22 Article
Johnson DE, Thompson TR, Green TP, Ferrieri P. Systemic candidiasis in very low-birth-weight infants (less than 1,500 grams). Pediatrics. 1984 Feb;73(2):138-43 Article
Bruyere A, Bourgeois J, Cochat P, Bethenod M. [Neonatal ulcero-necrotizing enterocolitis and aspergillosis]. Pediatrie. 1983 Apr-May;38(3):185-9 PubMed
Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981 Jul;71(1):59-66 Article
Granstein RD, First LR, Sober AJ. Primary cutaneous aspergillosis in a premature neonate. Br J Dermatol. 1980 Dec;103(6):681-4 Article
Gonzalez-Crussi F, Mirkin LD, Wyllie RM, Escobedo M. Acute disseminated aspergillosis during the neonatal period. Report of an instance in a 14-day-old infant. Clin Pediatr (Phila). 1979 Mar;18(3):137-8, 142-3 Article
Mangurten HH, Fernandez B. Neonatal aspergillosis accompanying fulminant necrotising enterocolitis. Arch Dis Child. 1979 Jul;54(7):559-62 Article
Steiner I, Jícha J, Otcenásek M, Vojt?ch K. [Case of spontaneous rupture of the stomach in a newborn infant with aspergillus gastritis]. Cesk Pediatr. 1979 Apr;34(4):235-8 PubMed
Burger PC, Graham DG, Burch JG, Hackel DB. Hemorrhagic cerebral white matter: infarction with cerebral deep venous thrombosis and hypoxia. Arch Pathol Lab Med. 1978 Jan;102(1):40-2 PubMed
Raaf JH, Donahoe PK, Truman JT, Robboy SJ. Aspergillus-induced small bowel obstruction in a leukemic newborn. Surgery. 1977 Jan;81(1):111-3 PubMed
[No authors listed]. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1976. N Engl J Med. 1976 Sep 9;295(11):608-14PubMed
Brass K. [Hospital infection of bronchopulmonary aspergillosis in infants and small children]. Mycopathologia. 1975 Dec 31;57(3):149-53 PubMed
Lazarus GM, Neu HC. Agents responsible for infection in chronic granulomatous disease of childhood. J Pediatr. 1975 Mar;86(3):415-7 PubMed
Wittig EO, Cat I, Kasting G. Meningencefalite a Aspergillus. Arq Neuropsiquiatr 1973; 31: 220-24.
Tan KK, Kenji S, Tan KL. Disseminated aspergillosis. Case report and review of the world literature. Am J Clin Pathol 1966; 45: 697-03.
Luke JL, Bolande RP, Gross S. Generalized aspergillosis and aspergillus endocarditis in infancy. Pediatrics 1963;31(1):115-122 Article
PARADIS AJ, ROBERTS L. Endogenous ocular aspergillosis. Report of a case in an infant with cytomegalic inclusion disease. Arch Ophthalmol. 1963 Jun;69:765-9 PubMed
Matturi L, Fasoli S. L’aspergillosi generalizzata neonatale. Osservazione anatomopatologica di un caso e revisione della litteratura. Folia Hereditaria Pathologica 1962; 12: 87-111.
Allan GW, Andersen DH. Generalized aspergillosis in an infant 18 days of age. Pediatrics. 1960 Sep;26:432-40 Article
AKKOYUNLU A, YUCEL FA. [Bronchopulmonary and encephalomeningeal aspergillosis in a 20-day-old newborn]. Arch Fr Pediatr. 1957;14(6):615-22 PubMed
Zimmerman LE. Fatal fungus infections complicating other diseases. Am J Clin Pathol. 1955 Jan;25(1):46-65 PubMed